Salesforce heads into its May 27 earnings with short sellers meaningfully re-engaged and the stock still carrying the weight of a bruising year.
The most notable development in CRM's positioning is the sharp mid-April rebuild in short interest. SI % of Free Float has climbed to 7.2% — but that headline masks a more dramatic move underneath. Shares short nearly doubled between early April and late April, jumping from roughly 39 million to a peak of 72 million before easing slightly to 68 million by May 5. The one-month change now reads +60%. That is not a gradual drift; it is a deliberate rebuilding of positions. The official FINRA fortnightly figure, settled at April 15, put short shares at 74 million with days to cover at 5.2 — a level that represents real conviction from the bearish side. The ORTEX short score of 53.4 sits in a broadly neutral zone but has been creeping higher over the past two weeks, reflecting the accumulation.
The borrow market, however, tells a more relaxed story. Cost to borrow runs at 0.47% — barely above the general collateral rate and up only 9% over the past month. Availability in the lending pool remains ample, with the share of borrowed stock relative to available supply sitting near 15%, well clear of the 52-week tight of 24.9%. That combination — a large short position built cheaply with plenty of room left to borrow — points to a fundamentally-driven short thesis rather than a borrow squeeze or a speculative pile-on. Options positioning is similarly calm. The put/call ratio of 0.80 tracks almost exactly in line with its 20-day average of 0.81, producing a z-score near zero. There is no unusual hedging demand and no directional tilt from the options market.
The Street remains broadly constructive but has been quietly trimming. The consensus holds at buy, with 27 buy-rated analysts on record, and the mean price target implies roughly 44% upside to the current $187 handle. That gap deserves scrutiny. Most of the recent target action clustered around the February earnings print, when bulls cut targets aggressively — JP Morgan from $365 to $320, TD Cowen from $325 to $250, Mizuho from $280 to $265. Piper Sandler, the most recent mover, trimmed its target from $250 to $215 in mid-April while holding its Overweight rating. The pattern is a consistent one: analysts maintain positive ratings but are bringing their numbers closer to where the stock is actually trading. At $187, CRM has already shed nearly 30% year-to-date, compressing the PE to around 13.5x — historically modest for a franchise of this scale. The EV/EBITDA of 9.8x tells a similar story of multiple contraction. Bulls point to Customer 360, the Agentforce AI layer, and recurring revenue durability. Bears flag accuracy issues in the AI product suite, intensifying competition, and cost pressure that could squeeze margins at exactly the wrong moment in the cycle.
Institutional holders are broadly stable. Vanguard added 4.1 million shares in Q1, Capital Research added 5.4 million, and Columbia Management added 3.9 million through April. CEO Marc Benioff remains a material holder at 2.7% of shares. On the insider activity front, Benioff sold 22,560 shares on April 22 at $189.80 for proceeds of roughly $4.3 million. Co-founders G. Parker Harris and co-president Srinivas Tallapragada executed similar same-day sales of a combined ~14,600 shares each — all paired with routine equity award grants. At trade_significance of 1, these are plan-driven disposals rather than statements of conviction, but the net 90-day insider position is a relatively modest $12 million in net proceeds, leaning toward the sell side.
The earnings history adds a useful frame. The most recent print, on February 25, produced a one-day gain of 7.6% and a five-day follow-through of 4.1%. That positive reaction came after a period of heavy short positioning and negative pre-earnings sentiment, suggesting the stock had been adequately de-risked into the release. The current setup has some similarities — a rebuilt short base, a depressed multiple, and the Agentforce narrative yet to fully crystallise in results. Among correlated peers, TEAM stands out this week with a stunning 32% one-week gain, likely reflecting an earnings beat that reset expectations for enterprise software productivity tools. HUBS and NOW are up 9% and 2% respectively on the week. CRM's 3% weekly gain is a quieter performance relative to the group — something to note as the sector broadly recalibrates.
The next focal point is the May 27 earnings release. What matters is less whether Agentforce is growing and more whether the company can demonstrate that AI-driven revenue is translating into margin accretion rather than just incremental cost.
See the live data behind this article on ORTEX.
Open CRM on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
